Premium
P1‐033: A MULTICENTER, RANDOMIZED, OPEN‐LABEL, PROSPECTIVE TRIAL TO EVALUATE THE SAFETY OF DONEPEZIL HYDROCHLORIDE 23 MG WITH OR WITHOUT INTERMEDIATE DOSE TITRATION IN PATIENTS WITH ALZHEIMER'S DISEASE TAKING DONEPEZIL HYDROCHLORIDE 10 MG: ODESA STUDY
Author(s) -
Hong Yun Jeong,
Han Hyun Jeong,
Youn Young Chul,
Park Kyung Won,
Yang Dong Won,
Kim SangYun,
Kim Hwa Jung,
Kim JI Eun,
Lee Jae-Hong
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.034
Subject(s) - donepezil , medicine , adverse effect , dementia , prospective cohort study , vital signs , randomized controlled trial , clinical trial , anesthesia , open label study , disease